Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial

0
0 / 5 (0 votos)

The Lancet Haematology

Fecha de publicación: 1 november 2018

DOI: https://doi.org/10.1016/S2352-3026(18)30155-8

Autores: Prof Takashi Watanabe, MD., Kensei Tobinai, MD., Masashi Wakabayashi, MSc., Yasuo Morishima, MD., Hirofumi Kobayashi, MD., Tomohiro Kinoshita, MD
et al.

Background: Standard treatment for untreated advanced-stage follicular lymphoma is rituximab plus chemotherapy. The incidence of histological transformation of follicular lymphoma has been reported only in heterogeneously treated populations and rarely with long-term follow-up.

Seguir leyendo